Ishida Kazuya, Horie Asuka, Nishimura Maki, Taguchi Masato, Fujii Nozomu, Nozawa Takashi, Inoue Hiroshi, Hashimoto Yukiya
Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama.
Drug Metab Pharmacokinet. 2013;28(6):491-6. doi: 10.2133/dmpk.dmpk-13-rg-017. Epub 2013 May 28.
We previously reported that renal function is partly responsible for the interindividual variability of the pharmacokinetics of bisoprolol. The aim of the present study was to examine the variability of bioavailability (F) of bisoprolol in routinely treated Japanese patients and intestinal absorption characteristics of the drug. We first analyzed the plasma concentration data of bisoprolol in 52 Japanese patients using a nonlinear mixed effects model. We also investigated the cellular uptake of bisoprolol using human intestinal epithelial LS180 cells. The oral clearance (CL/F) of bisoprolol in Japanese patients was positively correlated with the apparent volume of distribution (V/F), implying variable F. The uptake of bisoprolol in LS180 cells was temperature-dependent and saturable, and was significantly decreased in the presence of quinidine and diphenhydramine. In addition, the cellular uptake of bisoprolol dissolved in an acidic buffer was markedly less than that dissolved in a neutral buffer. These findings suggest that the rate/extent of the intestinal absorption of bisoprolol is another cause of the interindividual variability of the pharmacokinetics, and that the uptake of bisoprolol in intestinal epithelial cells is highly pH-dependent and also variable.
我们之前报道过,肾功能是比索洛尔药代动力学个体间差异的部分原因。本研究的目的是检测比索洛尔在常规治疗的日本患者中的生物利用度(F)变异性以及该药物的肠道吸收特征。我们首先使用非线性混合效应模型分析了52例日本患者的比索洛尔血浆浓度数据。我们还使用人肠上皮LS180细胞研究了比索洛尔的细胞摄取情况。比索洛尔在日本患者中的口服清除率(CL/F)与表观分布容积(V/F)呈正相关,这意味着F存在变异性。比索洛尔在LS180细胞中的摄取是温度依赖性且可饱和的,并且在奎尼丁和苯海拉明存在时显著降低。此外,溶解在酸性缓冲液中的比索洛尔的细胞摄取明显少于溶解在中性缓冲液中的情况。这些发现表明,比索洛尔肠道吸收的速率/程度是药代动力学个体间差异的另一个原因,并且比索洛尔在肠上皮细胞中的摄取高度依赖pH且也是可变的。